STACIA GALLION: Open Payments
NPI 1063479814 · JONESBORO, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,137 in 51 payments from 24 companies in 2025. Trend: 2023 $978 · 2024 $1,347 · 2025 $1,137
Food & beverage: $937Education: $200
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 3 | $130 |
| SEAGEN INC. | 1 | $100 |
| AstraZeneca Pharmaceuticals LP | 5 | $95 |
| Sumitomo Pharma America, Inc. | 4 | $86 |
| Novartis Pharmaceuticals Corporation | 4 | $78 |
| Merck Sharp & Dohme LLC | 4 | $72 |
| Exelixis Inc. | 4 | $65 |
| Incyte Corporation | 3 | $59 |
| ABBVIE INC. | 3 | $57 |
| Legend Biotech USA Inc. | 2 | $54 |
Products named: ORGOVYX, KEYTRUDA, CABOMETYX, CARVYKTI, PLUVICTO, BRUKINSA, JAKAFI, ELAHERE.
Industry payments across AR — which companies pay providers there.
